C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma.

MLA

Wilhelm, Raphael, et al. “C6 Ceramide (D18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma.” Cancers, vol. 13, no. 2, Jan. 2021. EBSCOhost, https://doi.org/10.3390/cancers13020270.

APA

Wilhelm, R., Eckes, T., Imre, G., Kippenberger, S., Meissner, M., Thomas, D., Trautmann, S., Merlio, J.-P., Chevret, E., Kaufmann, R., Pfeilschifter, J., Koch, A., & Jäger, M. (2021). C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma. Cancers, 13(2). https://doi.org/10.3390/cancers13020270

Chicago

Wilhelm, Raphael, Timon Eckes, Gergely Imre, Stefan Kippenberger, Markus Meissner, Dominique Thomas, Sandra Trautmann, et al. 2021. “C6 Ceramide (D18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma.” Cancers 13 (2). doi:10.3390/cancers13020270.